Cytori Therapeutics, Inc. (CYTX) Reports First Half and 2nd Quarter 2013 Business and Financial Results
8/9/2013 6:50:36 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Cytori Therapeutics (NASDAQ: CYTX) today reports its second quarter 2013 financial results and provides updates on clinical development and commercialization activities.
Total revenue for the six months and quarter ended June 30, 2013 were $6.0 million and $2.3 million, respectively. Net loss for the six months and quarter ended June 30, 2013 were $10.9 million and $3.2 million, respectively.
Hey, check out all the engineering jobs. Post your resume today!
comments powered by